5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data.

导出 OA

翻译打印收藏纠错

第一作者： Francesco,Del Giudice

第一单位： Department of Maternal Infant and Urologic Sciences, "Sapienza" University of Rome, Policlinico Umberto I Hospital, Rome, Italy. francesco.delgiudice@uniroma1.it.

作者： Francesco,Del Giudice ^[1] ; Federico,Belladelli ^[2] ; Frank,Glover ^[3] ; Satvir,Basran ^[4] ; Shufeng,Li ^[5] ; Evan,Mulloy ^[6] ; Benjamin,Pradere ^[3] ; Francesco,Soria ^[3] ; Wojciech,Krajewski ^[3] ; Rajesh,Nair ^[7] ; Wade,Muncey ^[8] ; Nicolas,Seranio ^[9] ; Michael L,Eisenberg ^[10]

作者单位： Department of Maternal Infant and Urologic Sciences, "Sapienza" University of Rome, Policlinico Umberto I Hospital, Rome, Italy. francesco.delgiudice@uniroma1.it. ^[1] Department of Urology, Stanford University School of Medicine, Stanford, CA, USA. francesco.delgiudice@uniroma1.it. ^[2] Department of Urology, Stanford University School of Medicine, Stanford, CA, USA. ^[3] University Vita-Salute San Raffaele, Milan, Italy. ^[4] Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy. ^[5] Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. ^[6] Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1030, Vienna, Austria. ^[7] Department of Urology, La Croix du Sud Hospital, 31130, Quint-Fonsegrives, France. ^[8] Urology Division, Department of Surgical Sciences, University of Studies of Torino, 10124, Turin, Italy. ^[9] Department of Minimally Invasive and Robotic Urology, Wrocław Medical University, 50-367, Wrocław, Poland. ^[10] Department of Urology, Guys and St, Thomas' NHS Foundation Trust, London, England. ^[11] Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA. ^[12]

关键词 5-alpha reductase inhibitor (5-ARi)Alpha blockers Benign prostatic hyperplasia Bladder cancer